228 Users Online
Single-use Cystoscope Market Segmentation By Product - (Flexible Single-use Cystoscope, Semi-Flexible Single-use Cystoscope)
The global revenue from the single-use cystoscope market was about US$ 76.5 Million in 2022, with the global market expected to grow at a CAGR of 8.5% to reach a valuation of about US$ 188.7 Million by the end of 2033.
Market Size (2023)
US$ 83.7 Million
Projected Market Value (2033)
US$ 188.7 Million
Global Market Growth Rate (2023 – 2033)
Market Share of Top 5 Countries (2022)
As assessed by Persistence Market Research, flexible video single-use cystoscope held a market share of around 86.6% in the global market, in 2022. Overall, single-use cystoscope market sales account for around 0.25% of revenue share in the global urology device market, which was valued at around US$ 30.4 Billion in 2022.
The single-use flexible cystoscope provides consistent quality without the need for reprocessing cleaning, or repairs in between procedures, and there is no risk of cross-contamination because sterile cystoscopes are used and discarded after each operation. Unlike rigid cystoscopes, flexible cystoscopes works in combination of both optical system and the working/irrigation channel into a single unit.
Cystoscopy procedure allows the urologist view the urinary tract, particularly the bladder, urethra, and the openings to the ureter. Cystoscopy is helpful in diagnosis and treatment of urinary tract problems. This include early signs of urinary tract cancers, painful urination (dysuria), stone in urinary tract, urinary tract infection (UTI), narrowing, enuresis (involuntary urination), blockage, or bleeding (hematuria).
The global single-use cystoscope market recorded a historic CAGR of 7.4% in the last 7 years from 2015 to 2022 due to high preference for flexible single-use cystoscope for various urinary tract problems.
Key players and hospitals are working for advanced techniques for minimizing cross-contamination as infection rates and healthcare acquired infections (HAIs) are on the rise. Single-use cystoscope helps decrease incidence of infections (both internal and external) and thus, demand for the same is expected to gain momentum over the forecast period.
The single-use cystoscope is portable, self- contained with its own light source, and video recording features, less recovery time due to minimally invasive procedure allowing it to be used in any office, clinics and hospitals.
Reusable cystoscope requires reprocessing after every procedure to maintain the sterility of cystoscope. Emerging countries lack inadequate reprocessing facilities as reprocessing requires proper facilities and trained professionals, thus creating more scopes for disposable or single-use medical devices. The potential reprocessing cost commonly associated with reusable endoscopes can also be minimized with use of single-use cystoscope.
Most companies offer online and international shipping, so the device can be ordered from anywhere globally. Online websites also aid in the promotion of products, resulting in better opportunities for players in the near future.
Organizations such as World Health Organization (WHO) and Center for Disease Control and Prevention (CDC) are conducting various awareness campaigns and programs which include training sessions and guidelines to educate people about hospital acquired infections and thus helping to prevent their occurrence and improve patient safety.
Thus, all these favorable opportunities are anticipated to expand the global market.
“Cystoscope Widening the Scope for Diagnosis of Urinary Tract Problems”
Cystoscopes are used to diagnose and treat urinary tract problems such as recurring UTI. A cystoscope can also be used to diagnose problems such as blood in the urine (hematuria). A cystoscope is also commonly used to diagnose a urethral or ureteral blockage or narrowing. Urologists use cystoscope to remove stones from the bladder and urethra and to treat urinary incontinence. To treat specific conditions, special tools can be passed through the cystoscope. A very small bladder tumor, for example, may be removed during cystoscopy.
UTI diagnosis and treatment are more difficult in the elderly population than in the younger population due to underlying risk factors such as older age, diabetes mellitus, dyslipidemia, hypertension, chronic kidney disease, spinal cord injuries, weakened immunity, and catheterization.
Single-use cystoscopes are used to have a better visual of the bladder and urethra due to the rising need for early detection and treatment of prostate and bladder cancer, which is driving the growth of the global market.
“Unskilled Professionals, Few Variety, and Side Effect after Cystoscopy Use”
Delivery of high-quality cystoscopy services largely depends on the capability of the cystoscopy specialist. Globally, the demand for cystoscopic procedures is increasing. Single-use cystoscope is also a new technology penetrating the market requiring highly skilled professionals for its operation. Hence, the growth of the global market can be affected due to the limited number of skilled professionals.
Currently, only few market players are offering single-use cystoscope in the market, thus buyers are left with fewer options to choose from. There are also many substitutes and alternatives available for single-use cystoscope in the market, thus limiting the growth of the global market. Many healthcare facilities have already invested in reusable cystoscopies. Thus the presence of few market players are hampering the growth of the global market over the forecast period.
There are several side effects associated with single-use cystoscope, which may last for one or two days after cystoscopy, such as mild burning urination, mild discomfort in kidney and bladder area, need to urinate more frequently, and small amount of blood in urine. Thus, these side effects are anticipated to hamper the adoption of the global market.
Why is the U.S. Market Booming?
“Increased Cystoscope Use in Finding Out Curable Causes of Recurrent UTIs”
The U.S. market held around 33.7% market share of the global market in 2022 because of prevalence of recurrent UTIs, especially in women.
Will the U.K. Be a Lucrative Market for Single-use Cystoscope Market?
“High Bladder Cancer Rate and Its High Cost Need Cystoscope for Cancer Early Detection”
The U.K. market held at about 5.6% market share of the global market in 2022 and it is anticipated to expand the global market due to the use of cystoscope for early detection of bladder cancer.
In the U.K., bladder cancer treatment is expensive, and hence it is anticipated to expand the global market of single-use cystoscope for early detection of cancer.
How is India Emerging As a Prominent Market?
“Unhygienic Toilet Practices will Rise the UTI”
India held a market share of about 4.4% of the global market in 2022 and it is expected to increase the global market due to inadequate and low quality sanitary infrastructure is the key challenge to avoid UTIs.
Which Type of Product is Driving Demand Within the Global Market?
“More Clinical Utilization of Flexible Video Single-Use Cystoscope Over Other Single-Use Cystoscope”
Flexible single-use cystoscope share was about 86.6% of the global market in terms of revenue in 2022 because of the clinical utilisation of flexible single-use cystoscope over rigid single-use cystoscope.
Flexible video single-use cyctoscope allows urologist and physician to see the urethra and bladder more clearly due to camera lenses and lower irrigation fluid flow in flexible cystoscopies. Flexible cystoscopy can be performed while the patient is awake. Thus, flexible cystoscopes are patient-friendly, less invasive and easy to use, propelling the flexible single-use cystoscope sector forward.
Which End User is Helping to Expand the Global Market?
“Various Cystoscopy Procedures Need to be done in the Hospitals by Skilled Health Workers”
By end user segment, hospitals segment held around 39.2% share of the global market in 2022 due to healthcare reimbursement policies and availability of skilled professionals for cystoscopy.
Cystoscopy is primarily done in hospitals because of availability of trained medical professionals or doctors to remove foreign bodies like bladder stones from the bladder using the proper surgical techniques.
Other reasons of use of cystoscope in hospitals by expertise are due to detect bladder cancer, cystitis, and benign prostatic hyperplasia as well as to look into the causes of bladder signs and symptoms, like hematuria, frequent UTIs, incontinence, and dysuria. In order to identify bladder cancer, this method can be done to acquire a biopsy or tissue sample from the bladder lining. Catheter insertion can also be done by cystoscopy (thin drainage tube of urine).
Other reason to expand hospitals end user is the healthcare reimbursement facility by various countries.
The key players are concentrating on launching new devices, developing devices that improve efficiency. The key players are primarily focused on new product line innovation and product expansion with partnership of domestic companies for commercialising high quality, cost-effective, disposable endoscopic products.
A few examples of strategies acquired by the key players:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the single-use cystoscope market, which are available in the full report.
2023 – 2033
Historical Data Available for
2015 – 2022
Key Countries Covered
Key Market Segments Covered
Key Companies Covered
Customization & Pricing
Available upon Request
The global market is valued at around US$ 76.5 Million in 2022.
The global market estimates for 2023 is around US$ 83.7 Million
The global market is set to reach valuation of around US$ 188.7 Million by the end of 2033
Sales of the market are set to witness growth at a CAGR of 8.5% between 2023 and 2033.
Demand for the global market increased at an 7.4% CAGR from 2015 to 2022.
Coloplast Group, NeoScope Inc., Asieris Pharmaceuticals, Stryker, Ambu, Olympus Medical Corporation, PENTAX Medical, Richard Wolf GmBH, Cogentix Medical, Karl Storz, Henke-Sass Wolf, Advanced Health Care Resources, and UroViu Corporation are the key players of the global market.
The U.S., Germany, China, U.K., and Japan are the top countries driving the global market with revenue share of around 58.1% in 2022.
The U.S. accounts for around 33.7% share of the global market in 2022.
The Indian market held a share of about 4.4% in the global market in 2022.
By Product, flexible single-use cystoscope will dominate the global market in 2023. Flexible cystoscopes held market share of around 86.6% in 2022 globally.